Olmesartan 40 mg + Hydrochlorothiazide 12.5 mg Tablets – OLBIX H 40/12.5

Olmesartan 40 mg + Hydrochlorothiazide 12.5 mg Tablets – A dual action therapy where monotherapy fails.

OLBIX H 40/12.5 – Olmesartan 40 mg + Hydrochlorothiazide 12.5 mg Tablets combination is an antihypertensive medicine which contains: Olmesartan, an ARB inhibitor (angiotensin receptor blocker) works by inhibiting angiotensin-II receptor and blocks the angiotensin hormone, resulting in relaxation and widening of blood vessels, decrease elevated blood pressure and enhances blood flow. Hydrochlorothiazide is a thiazide diuretic that inhibits sodium reabsorption in DCT and increases the excretion of sodium and water, decreasing blood volume. The reduction in blood volume leads to a decrease in cardiac output which makes the blood pressure lower, Combination helps in the management of hypertension, angina pectoris, and heart failure

Recommended by Specialists:
✅Cardiologist – For patients with heart attack and stroke
✅General Physicians – For long-term blood pressure control and prevention of hypertension-related complications.
✅Nephrologists – To protect kidney function in hypertensive patients, especially those at risk of chronic kidney disease.

Key Benefits of Olmesartan 40 mg + Hydrochlorothiazide 12.5 mg Tablets – OLBIX H 40/12.5
✅Synergistic action of dual therapy of vasodilator and diuretic provides a comprehensive approach with different to manage cardiac issues like hypertension, angina, stroke, and heart failure.
✅Dual Protection: As a combination has cardioprotective & nephroprotective benefits it is suitable for the management of cardiac patients with CKD, diabetes, and resistant hypertension.
✅Well tolerated as it minimizes side effects and once daily dosing is sufficient due to extended-release formulation, improves patient compliance.

Indications:
✅Hypertension
✅Resistant hypertension
✅Hypertension with CKD
✅Hypertension with Diabetes
✅Cardiovascular events (angina, stroke)